grant

T cells in the aging brain

Organization STANFORD UNIVERSITYLocation STANFORD, UNITED STATESPosted 15 Jun 2021Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY202521+ years oldAD dementiaAddressAdultAdult HumanAffectAgeAgingAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimers DementiaAntigensAssayBioassayBiological AssayBloodBlood Reticuloendothelial SystemBody TissuesBrainBrain Nervous SystemBrain regionCell BodyCell Communication and SignalingCell SignalingCell-Mediated Lympholytic CellsCellsCheckpoint inhibitorClonal ExpansionClone CellsCo-cultureCocultivationCocultureCoculture TechniquesCytolytic T-CellCytotoxic T CellCytotoxic T-LymphocytesDataDegenerative Neurologic DisordersDeteriorationElderlyEncephalonEndothelial CellsEnvironmental FactorEnvironmental Risk FactorEvaluationExerciseExhibitsGoalsHortega cellHumanIFNImmuneImmune checkpoint inhibitorImmune infiltratesImmune mediated therapyImmunesImmunofluorescenceImmunofluorescence ImmunologicImmunologically Directed TherapyImmunomodulationImmunotherapyImpairmentIn VitroIndividualInfiltrationInterferonsIntracellular Communication and SignalingKnowledgeLearningLibrariesLocationLytotoxicityMHC ReceptorMajor Histocompatibility Complex ReceptorMemoryMiceMice MammalsMicrogliaModern ManMurineMusNatural regenerationNerve CellsNerve UnitNervous SystemNervous System Degenerative DiseasesNeural CellNeural Degenerative DiseasesNeural Stem CellNeural degenerative DisordersNeurocyteNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Body SystemNeurologic Degenerative ConditionsNeurologic Organ SystemNeuronsNeurophysiology - biologic functionOlder PopulationOrganOrganismPlayPrevalencePrimary Senile Degenerative DementiaProductionProliferatingRegenerationRejuvenationRoleSignal TransductionSignal Transduction SystemsSignalingT cell infiltrationT cell receptor repertoire sequencingT cell receptor sequencingT cell regulationT-Cell Antigen ReceptorsT-Cell DepletionT-Cell ReceptorT-CellsT-LymphocyteT-cell depletion therapyT-lymphocyte depletion therapyTCR repertoire sequencingTCR sequencingTCR-seqTCRseqTestingTissuesWorkadulthoodadvanced ageage associated alterationsage associated changesage associated diseaseage associated disorderage associated impairmentage associated neurodegenerationage associated neurodegenerative diseaseage associated neurodegenerative disorderage correlated alterationsage correlated changesage dependent alterationsage dependent changesage dependent diseaseage dependent disorderage dependent impairmentage dependent neurodegenerationage dependent neurodegenerative conditionage dependent neurodegenerative diseaseage dependent neurodegenerative disorderage induced alterationsage induced changesage related alterationsage related changesage related human diseaseage related neurodegenerationage specific alterationsage specific changesage-driven neurodegenerative disordersage-related diseaseage-related disorderage-related impairmentage-related neurodegenerative diseaseage-related neurodegenerative disorderaged animalaged animalsaged brainagesaging associatedaging associated alterationsaging associated changesaging associated neurodegenerationaging associated neurodegenerative diseaseaging brainaging correlated alterationsaging correlated changesaging dependent alterationsaging dependent changesaging induced alterationsaging induced changesaging relatedaging related alterationsaging related changesaging related neurodegenerationaging related neurodegenerative diseaseaging related neurodegenerative disorderaging specific alterationsaging specific changesalterations with ageanimal old agebiological signal transductioncell typechanges with agecognitive enhancementcognitive functioncytokinecytotoxiccytotoxicitydecline in functiondecline in functional statusdegenerative diseases of motor and sensory neuronsdegenerative neurological diseaseselderly animalenvironmental riskexhaustionexperimentexperimental researchexperimental studyexperimentsfunctional declinefunctional restorationfunctional status declinegeriatricgitter cellglobal gene expressionglobal transcription profileimmune cell infiltrateimmune check point inhibitorimmune modulationimmune regulationimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimmunogenimmunologic reactivity controlimmunomodulatoryimmunoregulationimmunoregulatoryimprovedin vivoinsightkiller T cellliving systemmachine learning based modelmachine learning modelmesogliamicroglial cellmicrogliocytemid lifemid-lifemiddle agemiddle agedmidlifenatural agingnerve stem cellneural functionneural precursorneural precursor cellneural progenitorneural progenitor cellsneural stem and progenitor cellsneuroblastneurodegenerative illnessneurogenesisneurogenic progenitorsneurogenic stem cellneuron progenitorsneuronalneuronal progenitorneuronal progenitor cellsneuronal stem cellsneuroprogenitornormal agingnormative agingold animalsolder groupsolder individualsolder personperivascular glial cellpreservationpreventpreventingprimary degenerative dementiaprogenitor and neural stem cellsprogenitor cell nicheprogenitor cell proliferationprogenitor nicheprogenitor proliferationregenerateregenerativerejuvenating interventionrejuvenation approachrejuvenation strategiesrejuvenation therapyrejuvenation treatmentresponserestorationrestore functionrestore functionalityrestore lost functionscRNA sequencingscRNA-seqsenile dementia of the Alzheimer typesenior citizensingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingsocial rolestem and progenitor cell nichestem and progenitor cell proliferationstem cell nichestem cell proliferationsubventricular zonetherapeutic rejuvenationthymus derived lymphocytetranscriptome
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

SUMMARY
The overarching goal of this project is to understand how immune cells impact the brain during aging, with the

objective of restoring old brain function. The brain has long been considered an ‘immuno-privileged organ’.

However, recent studies have shown that immune cells infiltrate the brain in neurodegenerative diseases such

as Alzheimer’s disease and during aging. A key remaining challenge is to understand how immune cells impact

the brain during aging, and could this knowledge be used to restore functionality of old brain and treat

neurodegenerative diseases?

The subventricular zone (SVZ) of the adult brain provides a great paradigm to address this question, as this

regenerative region of the brain contains many different cell types – neural stem cells (NSCs), endothelial cells,

microglia – and exhibits clear functional decline during aging. To gain a single cell understanding of the changes

that occur with age in neurogenic niches, we recently performed single cell RNA-sequencing of young and old

neurogenic niches in mice. This analysis revealed a striking infiltration of cytotoxic T cells only in the old

neurogenic niche, which was confirmed by immunofluorescence. Surprisingly, we found that T cells from old

SVZs are clonally expanded and secrete interferon g (IFNg), suggesting that they have encountered specific

antigens. We also showed that T cells can impair NSC proliferation both in co-cultures and in vivo. Based on

these data, our specific hypothesis is that T cell clonal expansion in old brains drives the deterioration of the

neurogenic niche with age, and that preventing this T cell expansion restores function to old neurogenic regions.

Probing this idea would be critical to counter the decline in brain function during aging and neurodegenerative

diseases, such as Alzheimer’s disease. To test our hypothesis, we propose the following experiments:

1. To determine how T cells infiltrate neurogenic niches in old individuals;

2. To understand the functional impact of T cells on old neurogenic niches;

3. To examine the interaction between immune cells and neurogenic niches in young, old, and rejuvenated

individuals.

Completion of these aims will provide unique mechanistic insights into the regulation of T cell and other

immune cells during aging in regenerative niches of the brain. This work should also give a fundamental

understanding of the mechanistic impact of the interferon response and T cell cytotoxicity on different cell types

in the brain. Knowledge from our study should pave the way for building transformative strategies, including

new immunotherapies, for the restoration of a pristine tissue, which will be a critical step for improving brain

function during aging and age-related diseases such as Alzheimer’s disease.

Grant Number: 5R01AG071711-05
NIH Institute/Center: NIH

Principal Investigator: ANNE BRUNET

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →